The human dopamine D2(Longer) receptor has a high-affinity state and inhibits adenylyl cyclase

Molecular Brain Research

Volumn 77, Issue 2, 2000, Pages 281-284

  Liu, Ivy S C ^a,b   George, Susan R ^a,b   Seeman, Philip ^a,b  

^a Med Sci Bldg 8 Taddle Creek R ^*  (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

D2 mRNA; D2 splice variant; D2(Longer); Dopamine receptor; Psychosis

Indexed keywords

ADENYLATE CYCLASE; ANTIPARKINSON AGENT; COMPLEMENTARY DNA; DOPAMINE; DOPAMINE 2 RECEPTOR; ISOPROTEIN; NEUROLEPTIC AGENT; SPIPERONE;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; HORMONE RECEPTOR INTERACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY;

ADENYLATE CYCLASE; ALTERNATIVE SPLICING; ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; DOPAMINE; DOPAMINE ANTAGONISTS; ENZYME ACTIVATION; FORSKOLIN; GUANYLYL IMIDODIPHOSPHATE; HUMANS; RECEPTORS, DOPAMINE D2; SPIPERONE; THERMODYNAMICS;

ANIMALIA; PARKINSONIA;

EID: 0034608112     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(00)00064-4     Document Type: Article

References (17)

1. Bunzow J.R., Van Tol H.H.M., Grandy D.K., Albert P., Salon J., Christie M., Machida C.A., Neve K.A., Civelli O. Cloning and expression of a rat D2 dopamine receptor cDNA. Nature. 336:1988;783-787.
2. George S.R., Watanabe M., Di Paolo T., Falardeau P., Labrie F., Seeman P. The functional state of the dopamine receptor in the anterior pituitary is in the high-affinity form. Endocrinology. 117:1985;690-697.
3. Giros B., Sokoloff P., Martres M.-P., Riou J.-F., Emorine L.J., Schwartz J.-C. Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature. 342:1989;923-926.
4. 3H]Domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 332:1986;21-25.
5. 3H]Dopamine labeling of D3 dopaminergic sites in human, rat, and calf brain. J. Neurochem. 39:1982;1363-1373.
6. Valine194Glycine, is insensitive to dopamine and clozapine. Report of a homozygous individual. Am. J. Med. Gen. 61:1996;277-282.
7. Monsma F.J. Jr, McVittie L.D., Gerfen C.R., Mahan L.C., Sibley D.R. Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature. 342:1989;926-929.
8. Munson P.J., Rodbard D. A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:1980;220-239.
9. Ng G.Y.K., Varghese G., Chung H.T., Trogadis J., Seeman P., O'Dowd B.F., George S.R. Resistance of the dopamine D2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells. Endocrinology. 138:1997;4199-4206.
10. Onali P., Olianas M.C., Gessa G.L. Selective blockade of dopamine D1 receptors by SCH 23390 discloses striatal dopamine D2 receptors mediating the inhibition of adenylate cyclase in rats. Eur. J. Pharmacol. 9:1984;127-128.
11. Scheer A., Cotecchia S. Constitutively active G protein-coupled receptors: Potential mechanisms of receptor activation. J. Recept. Signal Transduct. Res. 17:1997;57-73.
12. Seeman P., Grigoriadis P. Dopamine receptors in brain and periphery. Neurochem. Int. 10:1987;1-25.
13. Seeman P., Tallerico T. Rapid release of antipsychotic drugs from dopamine D2 receptors: An explanation for low receptor occupancy and early clinical relapse upon drug withdrawal of clozapine or quetiapine. Am. J. Psychiatry. 156:1999;876-884.
14. Seeman P., Chau-Wong M., Tedesco J., Wong K. Brain receptors for antipsychotic drugs and dopamine: Direct binding assays. Proc. Natl. Acad. Sci. USA. 72:1975;4376-4380.
15. Longer, with unique TG splice site, in human brain. Mol. Brain Res. 76:2000;132-141.
16. 3H]spiperone depend on tissue concentration: analysis and examples. J. Neurochem. 43:1984;221-235.
17. Wreggett K.A., Seeman P. Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Mol. Pharmacol. 25:1984;10-17.